EXC vs IBIO · P/E 17, rev $24.26B vs rev $100.0K
Exelon Corporation (EXC) versus iBio, Inc. Common Stock (IBIO) — a side-by-side from cached financials, not a winner call.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
iBio, Inc. Common Stock (IBIO) is a biotechnology company listed on US.
Latest reported EXC revenue for 2025-12-31 was $24.26B. Net income was $2.77B. Revenue was up 5.3% from 2024-12-31 to 2025-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Latest reported IBIO revenue for 2026-06-30 was $100.0K. Net income was -$32.8M. Revenue was down 75.0% from 2025-06-30 to 2026-06-30. IBIO currently screens at market cap $13.4M.
EXC currently screens at market cap $47.33B and trailing P/E 16.8. IBIO currently screens at market cap $13.4M.
Not investment advice. Open the EXC and IBIO stock pages for the full models.
Not investment advice.